I-MAB (IMAB) Q2 2024 Earnings Call Transcript [Seeking Alpha]
I-MAB - American Depositary Shares (IMAB)
Company Research
Source: Seeking Alpha
Follow Play Earnings Call I-MAB Biopharma ( NASDAQ: IMAB ) Q2 2024 Earnings Conference Call August 28, 2024 8:00 AM ET Company Participants Sean Fu - Chief Executive Officer (interim) Phillip Dennis - Chief Medical Officer Joseph Skelton - Chief Financial Officer Tyler Ehler - Vice President, Investor Relations Conference Call Participants Joe Catanzaro - Piper Sandler Unknown Analyst - Jefferies Andres Maldonado - HC Wainwright Operator Greetings. Welcome to I-MAB Biopharma's first half 2024 financial results and corporate update conference call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If you would like to ask a question, please press star, one on your telephone keypad and a confirmation tone will indicate your line is in the question queue. You may press star, two if you'd like to withdraw your question from the queue. For participants that are using speaker equipment, it
Show less
Read more
Impact Snapshot
Event Time:
IMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMAB alerts
High impacting I-MAB - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMAB
News
- I-Mab to Participate at the Piper Sandler Healthcare ConferencePR Newswire
- I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.MarketBeat
- I-Mab Reports Third Quarter 2024 Results [Yahoo! Finance]Yahoo! Finance
- I-Mab Reports Third Quarter 2024 ResultsPR Newswire
- I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive OfficerPR Newswire
IMAB
Earnings
- 11/14/24 - Miss
IMAB
Sec Filings
- 11/14/24 - Form 6-K
- 11/6/24 - Form 6-K
- 11/5/24 - Form 6-K
- IMAB's page on the SEC website